Aptinyx Inc reported $192.93M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acorda Therapeutics ACOR:US $ 45.26M 955.08K
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
Biogen BIIB:US $ 42.17B 9.96B
Cara Therapeutics CARA:US $ 714.24M 368.58M
Daiichi Sankyo 4568:JP 4662.17B 2197.51B
Eli Lilly And LLY:US $ 220.12B 40.96B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Intra Cellular Therapies ITCI:US $ 3.32B 573.64M
IONIS PHARMACEUT IONS:US $ 5.62B 710.4M
Marinus Pharmaceuticals MRNS:US $ 657.2M 90.12M
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Novartis NOVN:VX 208.02B 8.76B
UCB UCB:BB 17.15B 715.78M
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B